12/5000 Rheumatic immune disease associated with pulmonary interstitial disease
Conditions
Interventions
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for this disease; 2. Meet the diagnostic criteria of TCM syndrome differentiation and classification of this disease; 3. Patients willing to actively cooperate with relevant examinations during the study; 4. Patients were enrolled under the condition of informed consent and signed informed consent; 5. For patients with pulmonary imaging manifestations that are typical but not clearly diagnosed and suspected to be rheumatic immune diseases mentioned above, 11 immunizations, ANA, ENA, dsDNA, ACL, ANCA, complement, and esR should be examined. Patients with rheumatic immunology disease may be clinically diagnosed by an experienced rheumatologist before they are included in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with other pulmonary diseases, such as bronchitis, chronic obstructive pulmonary disease, bronchiectasis, pleurisy, pulmonary hypertension, pulmonary tuberculosis, lung tumor, etc.; 2. Patients with other organs such as cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases and psychosis; 3. Patients who do not agree to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HRCT of the lung score; | — |
Countries
China
Contacts
Public ContactZhixiang Zhao
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed